Nvidia is Increasingly Focusing on Robotics as Competition in the AI Chips Space Toughens✎ Contributed by Ty Griffin As competition in the AI chips segment stiffens, Nvidia Corp. (NASDAQ: NVDA) is looking...
Ty Griffin
Chinese Automakers Shift Focus to Hybrids in Europe to Navigate EV Tariffs✎ Contributed by Ty Griffin In response to the European Union’s recent imposition of tariffs on electric...
U.S. Stock Markets Decline as Treasury Yields Rise✎ Contributed by Ty Griffin On December 27, 2024, U.S. stock markets experienced notable declines, influenced by...
Mullen Automotive (NASDAQ: MULN) Secures Class 3 EV Truck Order from Westland Floral✎ Contributed by Ty Griffin Mullen Automotive (NASDAQ: MULN) has received a purchase order for two Class 3...
Clene (NASDAQ: CLNN) Receives FDA Roadmap on Potential Accelerated Pathway for CNM-Au8(R)✎ Contributed by Ty Griffin Clene (NASDAQ: CLNN) and its wholly owned subsidiary, Clene Nanomedicine Inc., a late...
U.S. Stock Markets Experience Mixed Movements Following Holiday Break✎ Contributed by Ty Griffin On December 26, 2024, U.S. stock markets exhibited varied performances as trading...
Brera Holdings (NASDAQ: BREA) to Acquire Majority Stake in Italian Serie B Football Club Juve Stabia
Brera Holdings (NASDAQ: BREA) to Acquire Majority Stake in Italian Serie B Football Club Juve Stabia
Brera Holdings (NASDAQ: BREA) to Acquire Majority Stake in Italian Serie B Football Club Juve Stabia✎ Contributed by Ty Griffin Brera Holdings (NASDAQ: BREA), a Nasdaq-listed company specializing in multi-club ownership of...
Tech Giants Show Varied Market Performance as Industry Trends Evolve✎ Contributed by Ty Griffin As of December 23, 2024, leading technology companies have exhibited varied stock...
Gold Mining Sector Faces Geopolitical and Operational Challenges✎ Contributed by Ty Griffin The gold mining industry is navigating a complex landscape marked by geopolitical...
CVS Health Faces Regulatory Scrutiny, Impacting Stock Performance✎ Contributed by Ty Griffin CVS Health Corporation (NYSE: CVS) is encountering increased regulatory challenges, leading to...